Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA), Diclofenac Sodium Topical Solution USP, 2% w/w....
To leverage the research expertise and combined manufacturing capacities to introduce first-of-its-kind products in India, Akums Drugs & Pharmaceuticals Ltd, has partnered with Leiutis Pharmaceuticals LLP and Biophore India Pharmaceuticals for ...
Horizon Therapeutics Plc said on Tuesday its board was engaged in highly preliminary discussions with three pharmaceutical giants for potential takeover offers, sending its shares surging 31 per cent in extended trading...
Biocon Biologics completes acquisition of Viatris' global biosimilars bizNew Delhi, Biocon on Tuesday said its unit Biocon Biologics has completed the multi-billion dollar acquisition of the global biosimilars business of its partner Viatris Inc....
Global pharma major, Lupin Limited (Lupin) announced today that its wholly owned subsidiary in Brazil, MedQuÃmica Indústria Farmacêutica (MedQuÃmica), has signed a definitive agreement to acquire all rights to nine medicines from BL...
HOSMAT Hospital, the dedicated orthopaedic care provider has now installed the 3rd generation CUVIS robotic surgery unit, at its facility in Bengaluru. This is the 2nd medical centre in Karnataka to have this latest automated robotic system after...
Leading contract manufacturing drug firm Akums Drugs & Pharmaceuticals plans to expand its presence globally and enhance product range as it looks to more than double its turnover to Rs 10,000 crore by 2028, as per the company's Joint Managing...
Oxurion NV, a biopharmaceutical company, announced that it has prevailed in final proceedings before the European Patent Office in opposition to Dyax Corp.’s European patents 1 854 477 and 2 374 472. The European Board of Appeal announced its...
Oncologists at Apollo Cancer Centre, Bangalore have successfully performed endoscopic trans canal excision of facial nerve schwannoma on a 35-year-old patient who was suffering from right-sided facial weakness for the last two years....
Drug firm Eli Lilly and Company (India) said it has launched a product to treat early stage breast cancer after receiving approval from the Drug Controller General of India. The company has introduced Ramiven in strengths of 50 mg, 100 mg, 150 mg...
, CDSCO.jpg)
